


Theravab Biosciences Revenue
Biotechnology Research • Downtown Core, Central Region, Singapore • 1-10 Employees
Theravab Biosciences revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Theravab Biosciences
Narendra Patel
Chief Marketing Officer
Company overview
| Headquarters | Downtown Core, Central Region, Singapore |
| Website | |
| NAICS | 541714 |
| Founded | 2010 |
| Employees | 1-10 |
About Theravab Biosciences
TheraVab develops, produces and retails diagnostic and therapeutic human health products. These are based on proprietary recombinant monoclonal antibody techniques and small molecule inhibitors. Our product candidates and products emphasize particularly on disease segments with huge potential in the global market. These include neurodegenerative disorders, inflammatory diseases, cardiovascular diseases and oncology. At TheraVab, we make use of proprietary algorithms for designing, screening and choosing novel single domain monoclonal antibody fragments with particular affinity to various therapeutic targets and diseases molecules. We believe in harnessing the power of scientific research and cutting-edge technology towards a brighter and better future for humankind.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Theravab Biosciences has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Theravab Biosciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



